Research schools, which number between 150 and 200, used the inflow of federal dollars to build labs and other infrastructure ...

Medical device maker Abbott Laboratories maintained its annual profit forecast on Wednesday and said it expected the U.S.

Decoy Therapeutics, Inc. (Decoy), a privately held preclinical biopharmaceutical company engineering the next generation of peptide conjugate therapeutics, announces that Massachusetts Institute of ...

Winners of the ADGHW Innovation Awards 2025 addressed prenatal gene editing, robotic organ transplantation, precision drug ...

The company said China tariffs are hitting its products hardest and existing contracts limit its ability to raise prices.

For medical-technology and pharmaceuticals manufacturing, “the most effective answer is not tariffs but tax policy,” Johnson ...

The most substantial impact comes from tariffs against China and retaliatory tariffs from China. Health care giant Johnson & Johnson expects about $400 million in tariff-related costs this year.

For the first quarter of this year, J&J’s total sales of $21.9 billion were up 4.2% over the start of 2024, when accounting ...

Discover insights from Johnson & Johnson's Q1 2025 earnings call, highlighting 4.2% sales growth, MedTech innovation, and strategies to offset ...

We recently published a list of 10 Best Medical Stocks to Buy According to Billionaires. In this article, we are going to ...

The Food and Drug Administration is reversing course on its requirement for all staffers to report to the office.